215 related articles for article (PubMed ID: 22550316)
1. Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway.
Alzabin S; Abraham SM; Taher TE; Palfreeman A; Hull D; McNamee K; Jawad A; Pathan E; Kinderlerer A; Taylor PC; Williams R; Mageed R
Ann Rheum Dis; 2012 Oct; 71(10):1741-8. PubMed ID: 22550316
[TBL] [Abstract][Full Text] [Related]
2. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy.
Chen DY; Chen YM; Chen HH; Hsieh CW; Lin CC; Lan JL
Arthritis Res Ther; 2011 Jul; 13(4):R126. PubMed ID: 21801431
[TBL] [Abstract][Full Text] [Related]
3. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation.
Ye L; Jiang B; Deng J; Du J; Xiong W; Guan Y; Wen Z; Huang K; Huang Z
J Immunol; 2015 Jun; 194(11):5110-9. PubMed ID: 25917106
[TBL] [Abstract][Full Text] [Related]
4. IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro.
Boutet MA; Najm A; Bart G; Brion R; Touchais S; Trichet V; Layrolle P; Gabay C; Palmer G; Blanchard F; Le Goff B
Ann Rheum Dis; 2017 Jul; 76(7):1304-1312. PubMed ID: 28288964
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of a novel tylophorine analog, NK-007, on collagen-induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation.
Wen T; Li Y; Wu M; Sun X; Bao X; Lin Y; Hao J; Han L; Cao G; Wang Z; Liu Y; Wu Z; Hong Z; Wang P; Zhao L; Li Z; Wang Q; Yin Z
Arthritis Rheum; 2012 Sep; 64(9):2896-906. PubMed ID: 22576707
[TBL] [Abstract][Full Text] [Related]
6. [1,25(OH)2-Vitamin-D3 attenuates Th17-related cytokines expression in peripheral blood mononuclear cells in patients with early-diagnosed rheumatoid arthritis].
Wen H; Luo J; Zhang X; Zhang C; Zhao X; Wang X; Li X
Zhonghua Nei Ke Za Zhi; 2015 Apr; 54(4):317-21. PubMed ID: 26268060
[TBL] [Abstract][Full Text] [Related]
7. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.
McGovern JL; Nguyen DX; Notley CA; Mauri C; Isenberg DA; Ehrenstein MR
Arthritis Rheum; 2012 Oct; 64(10):3129-38. PubMed ID: 22674488
[TBL] [Abstract][Full Text] [Related]
8. TNFα promotes Th17 cell differentiation through IL-6 and IL-1β produced by monocytes in rheumatoid arthritis.
Zheng Y; Sun L; Jiang T; Zhang D; He D; Nie H
J Immunol Res; 2014; 2014():385352. PubMed ID: 25436214
[TBL] [Abstract][Full Text] [Related]
9. TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation.
van Hamburg JP; Asmawidjaja PS; Davelaar N; Mus AM; Cornelissen F; van Leeuwen JP; Hazes JM; Dolhain RJ; Bakx PA; Colin EM; Lubberts E
Ann Rheum Dis; 2012 Apr; 71(4):606-12. PubMed ID: 22219138
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of Oroxylin A in rheumatoid arthritis.
Wang YL; Gao JM; Xing LZ
Int Immunopharmacol; 2016 Nov; 40():294-299. PubMed ID: 27643663
[TBL] [Abstract][Full Text] [Related]
11. Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF
Bystrom J; Clanchy FI; Taher TE; Al-Bogami MM; Muhammad HA; Alzabin S; Mangat P; Jawad AS; Williams RO; Mageed RA
Clin Rev Allergy Immunol; 2017 Oct; 53(2):265-276. PubMed ID: 28488248
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
13. Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis.
Hull DN; Cooksley H; Chokshi S; Williams RO; Abraham S; Taylor PC
Arthritis Res Ther; 2016 Dec; 18(1):303. PubMed ID: 28010726
[TBL] [Abstract][Full Text] [Related]
14. L161982 alleviates collagen-induced arthritis in mice by increasing Treg cells and down-regulating Interleukin-17 and monocyte-chemoattractant protein-1 levels.
Chen L; Wu X; Zhong J; Li D
BMC Musculoskelet Disord; 2017 Nov; 18(1):462. PubMed ID: 29145862
[TBL] [Abstract][Full Text] [Related]
15. The anti-CD20 antibody rituximab reduces the Th17 cell response.
van de Veerdonk FL; Lauwerys B; Marijnissen RJ; Timmermans K; Di Padova F; Koenders MI; Gutierrez-Roelens I; Durez P; Netea MG; van der Meer JW; van den Berg WB; Joosten LA
Arthritis Rheum; 2011 Jun; 63(6):1507-16. PubMed ID: 21400475
[TBL] [Abstract][Full Text] [Related]
16. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
Stolina M; Schett G; Dwyer D; Vonderfecht S; Middleton S; Duryea D; Pacheco E; Van G; Bolon B; Feige U; Zack D; Kostenuik P
Arthritis Res Ther; 2009; 11(6):R187. PubMed ID: 20003323
[TBL] [Abstract][Full Text] [Related]
17. IL-25 attenuates rheumatoid arthritis through suppression of Th17 immune responses in an IL-13-dependent manner.
Liu D; Cao T; Wang N; Liu C; Ma N; Tu R; Min X
Sci Rep; 2016 Nov; 6():36002. PubMed ID: 27812008
[TBL] [Abstract][Full Text] [Related]
18. Enhanced and persistent levels of interleukin (IL)-17⁺ CD4⁺ T cells and serum IL-17 in patients with early inflammatory arthritis.
Gullick NJ; Abozaid HS; Jayaraj DM; Evans HG; Scott DL; Choy EH; Taams LS
Clin Exp Immunol; 2013 Nov; 174(2):292-301. PubMed ID: 23815507
[TBL] [Abstract][Full Text] [Related]
19. Diallyl Trisulfide can induce fibroblast-like synovial apoptosis and has a therapeutic effect on collagen-induced arthritis in mice via blocking NF-κB and Wnt pathways.
Liang JJ; Li HR; Chen Y; Zhang C; Chen DG; Liang ZC; Shi YQ; Zhang LL; Xin L; Zhao DB
Int Immunopharmacol; 2019 Jun; 71():132-138. PubMed ID: 30897500
[TBL] [Abstract][Full Text] [Related]
20. Targeting of circulating Th17 cells by β-D-mannuronic acid (M2000) as a novel medication in patients with rheumatoid arthritis.
Ahmadi H; Mahmoudi M; Gharibdoost F; Vojdanian M; Jamshidi AR; Fattahi MJ; Aghazadeh Z; Barati A; Mirshafiey A
Inflammopharmacology; 2018 Feb; 26(1):57-65. PubMed ID: 29063487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
